We are live on ! Find out more
ZYME icon

Zymeworks

46 hedge funds and large institutions have $130M invested in Zymeworks in 2018 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 15 increasing their positions, 9 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 9

30% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 10

8% more capital invested

Capital invested by funds: $121M → $130M (+$9.58M)

7% more funds holding

Funds holding: 4346 (+3)

5.36% less ownership

Funds ownership: 31.47%26.11% (-5.4%)

Holders
46
Holders Change
+3
Holders Change %
+6.98%
% of All Funds
1.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
15
Reduced
9
Closed
10
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
ECM
51
Element Capital Management
New York
-$155K -10,460 Closed
GWM
52
Geneos Wealth Management
Colorado
-$23K -1,588 Closed
Barclays
53
Barclays
United Kingdom
-$18K -1,248 Closed
Parallax Volatility Advisers
54
Parallax Volatility Advisers
California
-$16K -1,100 Closed

ZYME Hedge Fund Activity: Q3 2018 in Review

46 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q3 2018, worth a combined $130M — up 7.9% from $121M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new ZYME positions and 10 closed out — a net gain of 3 holders — while 15 added to existing stakes and 9 trimmed.

The largest buyer was Farallon Capital Management, adding an estimated $8.3M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $6.65M sold.

  • 46 institutional investors held Zymeworks (ZYME) as of Q3 2018, up from 43 in Q2 2018.
  • Funds reported $130M of Zymeworks stock for Q3 2018, up 7.9% quarter-over-quarter.
  • 13 funds opened new Zymeworks positions in Q3 2018 and 10 closed out, a net change of +3 holders.
  • The largest Zymeworks buyer in Q3 2018 was Farallon Capital Management, an estimated $8.3M added.
  • The largest Zymeworks seller in Q3 2018 was Alyeska Investment Group, an estimated $6.65M sold.

Based on aggregated 13F filings for Q3 2018.